Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ex Vivo Lung Perfusion Using Whole Blood: How?

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation·2019
Same author

Stripassay Genotyping for the Prediction of the Graft Relative Risk.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2017
Same author

Ex vivo lung perfusion; this idea deserves testing.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery·2017
Same author

Combined <i>Ex Vivo</i> Organ Perfusion and Mesenchymal Stem Cells Transplantation.

Journal of stem cells·2017
Same author

Mesenchymal stem cells transplantation during ex vivo lung perfusion.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2016
Same author

Ascorbic Acid Supplementation During Ex Vivo Lung Perfusion.

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation·2016

Related Experiment Video

Updated: Apr 15, 2026

Establishment of a Novel Ex Vivo Lung Perfusion System for Rat Lungs After Circulatory Death
09:14

Establishment of a Novel Ex Vivo Lung Perfusion System for Rat Lungs After Circulatory Death

Published on: October 18, 2024

1.2K

Could Ex Vivo Lung Perfusion Be a Platform to Decrease the Incidence of Chronic Lung Allograft Dysfunction?

Mohamed S A Mohamed1

  • 1Department of Thoracic Transplantation, University Clinic Essen, Essen, Germany.

Archives of Medical Research
|March 31, 2015
PubMed
Summary
This summary is machine-generated.

Lung transplantation faces challenges with graft shortage and chronic allograft dysfunction (CLAD). Ex vivo lung perfusion may offer protection against CLAD development by modulating Toll-like receptor activation.

Keywords:
Ex vivo lung perfusionGraft rejectionLung transplantationToll-like receptorVersican and chronic allograft dysfunction

More Related Videos

Establishment of an Ex Vivo Lung Perfusion Rat Model for Translational Insights in Lung Transplantation
05:49

Establishment of an Ex Vivo Lung Perfusion Rat Model for Translational Insights in Lung Transplantation

Published on: September 29, 2023

1.2K
Isolated Lung Perfusion System in the Rabbit Model
10:18

Isolated Lung Perfusion System in the Rabbit Model

Published on: July 15, 2021

4.3K

Related Experiment Videos

Last Updated: Apr 15, 2026

Establishment of a Novel Ex Vivo Lung Perfusion System for Rat Lungs After Circulatory Death
09:14

Establishment of a Novel Ex Vivo Lung Perfusion System for Rat Lungs After Circulatory Death

Published on: October 18, 2024

1.2K
Establishment of an Ex Vivo Lung Perfusion Rat Model for Translational Insights in Lung Transplantation
05:49

Establishment of an Ex Vivo Lung Perfusion Rat Model for Translational Insights in Lung Transplantation

Published on: September 29, 2023

1.2K
Isolated Lung Perfusion System in the Rabbit Model
10:18

Isolated Lung Perfusion System in the Rabbit Model

Published on: July 15, 2021

4.3K

Area of Science:

  • Transplantation immunology
  • Surgical innovation
  • Pulmonary medicine

Background:

  • Increasing demand for lung transplantation exceeds donor availability.
  • Chronic allograft dysfunction (CLAD) affects 43-80% of lung transplant recipients within 5 years.
  • Toll-like receptor activation is implicated in numerous CLAD risk factors.

Purpose of the Study:

  • To provide an overview of CLAD development post-lung transplantation.
  • To explore the potential protective role of ex vivo lung perfusion (EVLP) in mitigating CLAD.
  • To discuss the link between Toll-like receptors and CLAD pathogenesis.

Main Methods:

  • Literature review and expert overview.
  • Analysis of risk factors contributing to CLAD.
  • Evaluation of ex vivo lung perfusion as a protective strategy.

Main Results:

  • CLAD is a major complication of lung transplantation with high incidence.
  • Toll-like receptor activation is a common pathway in CLAD development.
  • Ex vivo lung perfusion is a promising technique for increasing graft availability.

Conclusions:

  • Understanding CLAD pathogenesis is crucial for improving long-term transplant outcomes.
  • Ex vivo lung perfusion may offer a novel approach to reduce CLAD incidence.
  • Further research is warranted to elucidate the mechanisms by which EVLP protects against CLAD.